Abstract Body

Background: The role of immune activation and inflammation on the rate of HIV disease progression has been proposed as a critical determinant of pathogenesis, but the mechanism is not fully understood. HIV+ individuals with HIV- partners (discordant relationship) versus HIV+ partners (concordant relationship) provide valuable insight to the role of continued HIV exposure on the clinical course of HIV infection. This study compared the impact of systemic viral load, T cell activation and inflammatory cytokine profiles on rate of disease progression in HIV+ concordant and discordant couples.

Methods: The impact of sexual partner status on systemic immune activation and inflammatory cytokine production in HIV+ individuals in HIV concordant (n=195) or discordant (n=142) long-term relationships was determined by flow cytometric analysis and luminex assays. Sequencing and qPCR were performed to determine CCR5 haplotypes.

Results: HIV+ concordant individuals had 0.5 Log10 higher plasma viral loads than HIV+ discordant ones (p<0.0001), and this was maintained over 24 months. However, this did not predict worse disease outcome (measured by absolute blood CD4 counts at later time points). HIV+ concordant individuals had higher frequencies of activated T-cells (CD3+CD38+CCR5+) in blood than HIV+ discordant counterparts. Individuals with plasma HIV loads >1500 copies/ml had higher frequencies of CD4+CCR5+ (p=0.007), CD8+CD38+ (p=0.01) and CD8+HLA-DR+CD38+ (p=0.01) T-cells compared to individuals with plasma viral loads <1500 cps/ml. CCR5 promoter haplotypes were not found to be a determinant in the CCR5 expression levels by T-cells. HIV+ concordant individuals had significantly higher concentrations of IL-1β (p=0.04) and TNF-α (p=0.03) in plasma than HIV+ discordant individuals. In women, plasma viral loads predicted genital tract viral loads (Rho=0.65; p<0.0001), with HIV+ concordant women having higher genital viral loads than HIV+ discordant women (p=0.001). HIV+ women with detectable HIV in genital secretions had higher genital concentrations of IP-10 (p=0.002), IL-1α (p=0.007), IL-1β (p=0.004), IL-6 (p=0.005), IL-8 (p=0.008), MCP-1 (p=0.03), MIP-1β (p=0.01), IL-10 (p=0.01), and G-CSF (p=0.002) than those with no detectable genital HIV.

Conclusions: This study suggests that partner’s HIV status influences systemic viral loads, immune activation and inflammation, and is potentially a key factor ensuring continued HIV replication, but did not influence disease outcome.